Remove 3D Remove Biotech Remove Machine Learning Remove Software Engineering
article thumbnail

Genesis Therapeutics raises $52M A round for its AI-focused drug discovery mission

TechCrunch

Sifting through the trillions of molecules out there that might have powerful medicinal effects is a daunting task, but the solution biotech has found is to work smarter, not harder. Machine learning has, of course, accelerated work in many fields, biochemistry among them, but he felt that the potential of the technology had not been tapped.

Biotech 265
article thumbnail

AI in Drug Discovery and Repurposing: Benefits, Approaches, and Use Cases

Altexsoft

So, it comes as no surprise that all large biopharma companies are investing in AI, particularly in deep learning , which has the potential to make the hunt for drugs cheaper, faster, and more precise. It’s worth noting that regulatory bodies treat the use of machine learning in healthcare with caution. Source: Deloitte.